Adenoviral gene therapy for liver metastases of gastrointestinal tumours;Adenovirale Gentherapie bei Lebermetastasen gastrointestinaler Tumoren

Deutsche Medizinische Wochenschrift

Volumn 122, Issue 22, 1997, Pages 728-732

  Block, A ^a   Windler, E ^a   Greten, H ^a   Woo, S L C ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; GASTROINTESTINAL TUMOR; GENE THERAPY; HUMAN; LIVER METASTASIS; SHORT SURVEY;

EID: 0030920487     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1047681     Document Type: Short Survey

References (17)

1. Addison, C., T. Braciak, L. Levy, R. Ralston, W. J. Muller, J. Gauldie, F. L. Graham: Gene therapy of cancer using recombinant adenovirus vectors expressing cytokines. Gene Therapy 1 (1994).
2. Bett, A. J., L. Prevec, F. L. Graham: Packaging capacity and stability of human adenovirus type 5 vectors. J. Virol. 67 (1993), 5911-5921.
3. Blaese, M., T. Blankenstein, M. Brenner, O. Cohen-Haguenauer, B. Gansbacher, S. Russell, B. Sorrentino, T. Velu: Vectors in cancer therapy. How will they deliver? Cancer Gene Therapy 2 (1995), 291-297.
4. Block, A., S. H. Chen, K. I. Kosai, M. Finegold, S. L. Woo: Adenoviral mediated herpes simplex thymidine kinase gene transfer. Regression of hepatic metastasis of pancreatic tumors. Pancreas, in press (1997).
5. Caruso, M., K. P. Nguyen, Y. L. Kwong, B. Xu, K. I. Kosai, M. Finegold, S. L. Woo, S. H. Chen: Adenovirus-mediated Interleukin-12 gene therapy for metastatic colon carcinoma. Proc. nat. Acad. Sci. 93 (1996), 11302-11306.
6. Chen, S. H., K. I. Kosai, B. Xu, K. P. Nguyen, C. Contant, M. J. Finegold, S. L. Woo: Combination suicide and cytokine gene therapy for heatic metastasis of colon carcinoma. Sustained antitumoral immunity prolongs animal survival. Cancer Research 56 (1996), 3758-3762.
7. Chen, S. H., H. D. Shine, J. C. Goodmann, R. C. Grossman, S. L. Woo: Gene therapy for brain tumor. Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo (Meeting abstract). Proc. ann. Meet. Amer. Ass. Cancer Res. 35 (1994).
8. Connors, T. A.: The choice of prodrugs for gene directed enzyme prodrug therapy for cancer. Gene Therapy 2 (1995), 702-709.
9. Cristiano, R. J., J. A. Roth: Molecular conjugates. A targeted gene delivery vector for molecular medicine. J. molec. Med. 73 (1995), 479-486.
10. Culver, K. W., R. M. Blaese: Gene therapy for cancer. Trends in Genetics 10 (1994), 174-178.
11. Gansbacher, B.: Cytokine gene therapy. Mt. Sinai J. Med. 61 (1994), 301-309.
12. Glorioso, J. C., N. A. DeLuca, D. J. Fink: Development and application of herpes simplex virus vectors for human gene therapy. Ann. Rev. Microbiol. 49 (1995), 675-710.
13. Grossman, M., J. M. Wilson: Retroviruses. Delivery vehicle to the liver. Curr. Opin. Genet. Develop. 3 (1993), 110-114.
14. Jolly, D.: Viral vector systems for gene therapy. Cancer Gene Therapy 1 (1994), 51-64.
15. Lebovic, G. S., J. E. Niederhuber: Curr. Then Oncol. J. (1993), 389-395.
16. Moolten, F. L: Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes. Paradigm for a prospective cancer control strategy. Cancer Research 46 (1986), 5276-5281.
17. Samulski, R. J., X. Zhu, X. Xiao, J. D. Brook, D. E. Housman, N. Epstein, L. A. Hunter: Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10 (1991), 3941-3950. Erratum in EMBO J. 11 (1992), 1228.